← Back to headlines
India Approves Novo Nordisk's Wegovy for Fatty Liver Disease Treatment
India's drug regulator, CDSCO, has granted approval for Novo Nordisk's weight-loss drug Wegovy (semaglutide injection 2.4 mg) to treat noncirrhotic metabolic dysfunction associated steatohepatitis (MASH) in adults.
17 Jul, 09:05 — 17 Jul, 09:05
